CN109652202A - A kind of intelligence development safflower tea oil and preparation method thereof - Google Patents
A kind of intelligence development safflower tea oil and preparation method thereof Download PDFInfo
- Publication number
- CN109652202A CN109652202A CN201910059032.1A CN201910059032A CN109652202A CN 109652202 A CN109652202 A CN 109652202A CN 201910059032 A CN201910059032 A CN 201910059032A CN 109652202 A CN109652202 A CN 109652202A
- Authority
- CN
- China
- Prior art keywords
- oil
- tea
- safflower
- tea oil
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000010495 camellia oil Substances 0.000 title claims abstract description 73
- 244000020518 Carthamus tinctorius Species 0.000 title claims abstract description 63
- 235000003255 Carthamus tinctorius Nutrition 0.000 title claims abstract description 63
- 238000011161 development Methods 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 35
- 239000003921 oil Substances 0.000 claims abstract description 32
- 240000004638 Dendrobium nobile Species 0.000 claims abstract description 23
- 235000005638 Austrian pine Nutrition 0.000 claims abstract description 22
- 235000008565 Pinus banksiana Nutrition 0.000 claims abstract description 22
- 235000013264 Pinus jeffreyi Nutrition 0.000 claims abstract description 22
- 235000008578 Pinus strobus Nutrition 0.000 claims abstract description 22
- 235000008585 Pinus thunbergii Nutrition 0.000 claims abstract description 22
- 235000014030 Podocarpus spicatus Nutrition 0.000 claims abstract description 22
- 235000017985 rocky mountain lodgepole pine Nutrition 0.000 claims abstract description 22
- 244000019397 Pinus jeffreyi Species 0.000 claims abstract description 21
- 239000003814 drug Substances 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 13
- 238000004519 manufacturing process Methods 0.000 claims abstract description 11
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 8
- 244000147058 Derris elliptica Species 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims abstract description 6
- 230000010355 oscillation Effects 0.000 claims abstract description 6
- 238000001914 filtration Methods 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 241001122767 Theaceae Species 0.000 claims description 44
- 238000001035 drying Methods 0.000 claims description 11
- 238000003825 pressing Methods 0.000 claims description 9
- 238000002137 ultrasound extraction Methods 0.000 claims description 5
- 241000526900 Camellia oleifera Species 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 abstract description 9
- 230000036039 immunity Effects 0.000 abstract description 8
- 238000000605 extraction Methods 0.000 abstract description 5
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000006837 decompression Effects 0.000 abstract description 2
- 244000269722 Thea sinensis Species 0.000 abstract 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract 1
- 230000001151 other effect Effects 0.000 abstract 1
- 235000013616 tea Nutrition 0.000 description 37
- 235000019198 oils Nutrition 0.000 description 28
- 210000000265 leukocyte Anatomy 0.000 description 23
- 230000018109 developmental process Effects 0.000 description 17
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 15
- 229960004397 cyclophosphamide Drugs 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 230000006870 function Effects 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 8
- 239000007928 intraperitoneal injection Substances 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 239000008157 edible vegetable oil Substances 0.000 description 6
- 238000011049 filling Methods 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000003712 anti-aging effect Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 210000001541 thymus gland Anatomy 0.000 description 5
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 5
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 241000609666 Tuber aestivum Species 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 239000004519 grease Substances 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 3
- 235000010254 Jasminum officinale Nutrition 0.000 description 3
- 240000005385 Jasminum sambac Species 0.000 description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 235000019485 Safflower oil Nutrition 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 3
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 239000013256 coordination polymer Substances 0.000 description 3
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 230000003760 hair shine Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 3
- 229960004488 linolenic acid Drugs 0.000 description 3
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000000050 nutritive effect Effects 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000003813 safflower oil Substances 0.000 description 3
- 235000005713 safflower oil Nutrition 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 238000007619 statistical method Methods 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- JSPNNZKWADNWHI-PNANGNLXSA-N (2r)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]heptadecanamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@H]([C@H](O)\C=C\CC\C=C(/C)CCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JSPNNZKWADNWHI-PNANGNLXSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QGXBDMJGAMFCBF-HLUDHZFRSA-N 5α-Androsterone Chemical compound C1[C@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 QGXBDMJGAMFCBF-HLUDHZFRSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- QGXBDMJGAMFCBF-UHFFFAOYSA-N Etiocholanolone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC21 QGXBDMJGAMFCBF-UHFFFAOYSA-N 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 102000010909 Monoamine Oxidase Human genes 0.000 description 2
- 108010062431 Monoamine oxidase Proteins 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 235000021319 Palmitoleic acid Nutrition 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 229940061641 androsterone Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 229930183167 cerebroside Natural products 0.000 description 2
- RIZIAUKTHDLMQX-UHFFFAOYSA-N cerebroside D Natural products CCCCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O RIZIAUKTHDLMQX-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- -1 lipid peroxide Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 150000003408 sphingolipids Chemical class 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 230000002992 thymic effect Effects 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241001523681 Dendrobium Species 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 244000251141 Podocarpus spicatus Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- WWULHQLTPGKDAM-UHFFFAOYSA-N gamma-eudesmol Natural products CC(C)C1CC(O)C2(C)CCCC(=C2C1)C WWULHQLTPGKDAM-UHFFFAOYSA-N 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000008271 nervous system development Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229940033080 omega-6 fatty acid Drugs 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 1
- 229930001895 zingiberene Natural products 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/02—Pretreatment
- C11B1/04—Pretreatment of vegetable raw material
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/06—Production of fats or fatty oils from raw materials by pressing
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
- C11B3/001—Refining fats or fatty oils by a combination of two or more of the means hereafter
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of intelligence development safflower tea oils, it is characterised in that raw material composition are as follows: 3000-3500 grams of the dry tea fruit of Tengchong safflower tea oil tree, 150-180 grams of fructus alpiniae oxyphyllae, and 60-90 grams of lip dendrobium nobile of comb, 80-120 grams of black pine.It is extracted by the preparation of the squeezing of safflower tea oil, traditional Chinese medicine powder and wild mushroom powder, supersonic oscillations, the production method of finished product filtering obtains.The beneficial effects of the invention are as follows safflower tea oil is obtained using low-temperature cold-squeezing, the nutriment in oil is remained；The effective component in Chinese medicine and wild mushroom is obtained using supersonic oscillations extractive technique, increase the edible value and health-care efficacy of oil, has and increase immunity, lipid-loweringing, decompression, hypoglycemic and other effects, and squeezing and extraction process are simple, it is at low cost, there is broad mass market prospect.
Description
Technical field
The invention belongs to a kind of natural edible oil with health care function more particularly to a kind of intelligence development safflower tea oil and its systems
Make method.
Background technique
As the improvement of people's living standards, the requirement to edible oil also steps up, it is desirable to which edible oil can have nutrition
With the dual function of health care.Though presently commercially available edible oil has basic nutrition element, lack healthcare function.This money is not only nutritious but also has
The intelligence development safflower oil of healthcare function, not only containing the micro member such as 18 kinds of amino acid, vitamin E and the necessary potassium of human body, calcium, zinc
Element is also rich in 80% or more unsaturated fatty acid.The acid generates eicosapentaenoic acid under the action of human liver's enzyme
(EPA) and docosahexaenoic acid (DHA).EPA is medically known as " blood vessel scavenger ", and long-term consumption is to suffering from " three high "
The people of (hyperlipidemia, hypertension, hyperglycemia), cardiovascular and cerebrovascular patient, fatty liver, obesity have ideal effect.DHA is still
Main component in human brain and retina, it is effective to raising IQ and enhancing eyesight.Contained ω -3 in safflower tea oil
Fatty acid (linolenic acid) and ω -6 fatty acid (linoleic acid) be human body itself cannot synthesize but required fatty acid, so also crying
Essential fatty acid.
This tea oil is rich in natural VE, squalene, tea polyphenols etc..Vitamin E constitutes anti-oxidant system together with a variety of enzymes
System, protects human body cell from the injury of free radical, therefore can anti-aging, moreover it is possible to improve immunity.The safflower tea oil of Gaoligong Shan Mountain
Unsaturated fatty acid content is up to 80-90%.Also contain a variety of volatility oils, multivitamin and microelement in fructus alpiniae oxyphyllae,
These ingredients have medicinal effects；Wild mushroom rich in protein, amino acid, unsaturated fatty acid and sphingolipid, cerebroside,
Ceramide, sterol etc., so all having higher nutritive value and health-care efficacy in raw materials used in this invention.
The present invention is directed to sufficiently develop reproducible safflower oil tea and relevant " food and medicament dual-purpose " plant in Gaoligong Shan Mountain, this
It is not only advantageous for the peasant programme in mountain area, product can also be sub-health population (containing the elderly) and people with high income (enterprise
Family, enterprises and institutions senior executive and white collar etc.) a kind of pure natural functional edible oil is provided；The oil can also become pregnant woman and
The nutrition of infant, oil for health care.
Because intelligence development safflower tea oil has adapted to the demand of society instantly, it is contemplated that market acceptance will be higher.
Summary of the invention
The purpose of the present invention: providing a kind of intelligence development safflower tea oil, and using the oily fruit of Gaoligong Shan Mountain safflower oil tea, low temperature dries
The techniques such as dry, hydraulic cold are prepared into safflower tea oil, and two taste of compatibility " food and medicament dual-purpose " plant and a kind of wild mushroom in the oil, then
With ultrasonic technology, safflower tea oil, fructus alpiniae oxyphyllae, comb lip dendrobium nobile, the effective component in black pine is made to organically blend, it is manufactured
This money functionality edible oil.The oil has the effect of improving immunity of organisms, reducing " three high ", to achieve the goals above, this
Invention the technical solution adopted is as follows:
A kind of intelligence development safflower tea oil, it is characterised in that raw material composition are as follows: 3000 grams of the dry tea fruit-of Tengchong safflower tea oil tree
3500 grams, 150 grams -180 grams of fructus alpiniae oxyphyllae, comb 60 grams -90 grams of lip dendrobium nobile, 80 grams -120 grams of black pine.
It is another object of the present invention to: a kind of production method of intelligence development safflower tea oil is provided, it is characterized in that:
1, safflower tea oil squeezes:
(1) stack retting: the camellia oleifera fruit of collection is placed on indoor stack retting 6-8 days, allows tea seed to play afterripening, to increase oil.
(2) sunning, broken shell: the tea fruit after stack retting is shone above after 3-5 days, and the tea seed of tea fruit nature broken shell, tea fruit can separate,
Then it selects, be sieved, Yang Jing, continuing to shine 10-12 days, the organic matters such as starch and soluble sugar is made to be fully converted into grease.It shines
Tea seed be put at aeration-drying collect, when tea seed oil content reaches highest after 40-60 days, then again solarization 1-2 days to mention
High oil recovery, to ensure tea oil quality.
(3) it dries, crush: by tea seed decladding, being placed in 50-60 DEG C of baking oven and dried, control the moisture content of tea seed
Tea seed is crushed in 5%-8%, then with pulverizer.
(4) cold pressing: tea seed being placed in squeezer and is squeezed, and the temperature of squeezing is 50-60 DEG C.
(5) filter: the oily coarse filtration that squeezing is completed, the oil that squeezing is completed sequentially pass through the sieve of 60,80,100 mesh,
It is standby at normal temperature to deposit, obtain 1020 grams -1225 grams of safflower tea oil.
2, the fructus alpiniae oxyphyllae fruit, comb lip dendrobium nobile, black pine the preparation of Chinese medicine and wild mushroom: are placed on to 50-60 DEG C of baking
It is dried in case；Again fructus alpiniae oxyphyllae fruit, comb lip dendrobium nobile, black pine are carried out being ground into coarse powder with pulverizer after drying.
3, supersonic oscillations: under normal temperature conditions, by the fructus alpiniae oxyphyllae fruit, comb the lip dendrobium nobile, black pine in the step 2
Dew coarse powder is put into the step 1 safflower tea oil obtained, is placed in ultrasonic extraction tank together, and ultrasonic device 20- is opened
40 minutes, ultrasonic frequency 20-60kHz, merge three taste medicinal materials sufficiently with the effective component in safflower tea oil.
4, finished product filters: the safflower tea oil in the step 3 being filtered by supercentrifuge, it is red to finally obtain intelligence development
918-1103 grams of finished product of jasmine tea oil.
Raw material employed in the present invention:
Tengchong Gaoligong Shan Mountain safflower tea oil tree is the exclusive rare traditional oil tree in China.The food medicine of safflower tea oil is dual
Function is recorded in the Classic of Mountains and Rivers of 3rd century BC earliest, and rear Compendium of Material Medica, " agricultural administration book ", " medical university takes leave in China
Allusion quotation ", " Chinese Pharmacopoeia ", on the documents such as " clinical pediatric magazine ".Through the ages effect of the related pharmaceutical mechanism to safflower tea oil
Mechanism and pharmacodynamics have research more: energy calming the liver benefit lung, qi-regulating decompression, stomach-invigorating intestine-moisturizing enhance heart vigor, press down fat, anti-aging,
And nervous system development can be promoted, improve memory and retinal reflex ability, moreover it is possible to prevent cardiovascular and cerebrovascular disease and fatty liver, also
It offsets to move back pulse atherosclerosis and antithrombus formation and improve immunity of organisms and has certain effect.Some researches show that Sufflower teas
Oil acts on pregnant woman and infant beneficial to benefit.
It is examined through warehouse Zhu Shihui qualitative control department, Japanese grease association and Analysis Test Inst., Yunnan Prov., Tengchong safflower
Unsaturated fatty acid content is 81.6% in tea oil, wherein oleic acid accounts for 69.27%, and linoleic acid accounts for 10.36%, and linolenic acid accounts for
1.62%, palmitoleic acid accounts for 0.1%, and arachic acid accounts for 0.11%, and erucic acid accounts for 0.09%；It is also necessary rich in vitamin E and human body
The microelements such as potassium, calcium, zinc.
Fructus alpiniae oxyphyllae thinks that fructus alpiniae oxyphyllae energy tonifying kidney and strengthening yang, controlling nocturnal emission with astringent drugs temperature spleen please color macrobiosis, enhancing note in ancient Chinese medicine doctor treatise
Recall, long term usage is made light of one's life by commiting suicide, and is kidney tonifying health care good medicine simply.It is confirmed according to modern pharmacological research, fructus alpiniae oxyphyllae contains multiple compounds, can enhance
The immune function of Aged Mice can also increase the leucocyte in mouse peripheral blood.Fructus alpiniae oxyphyllae contains volatile oil, and main component is eucalyptus
The sesquiterpenoids such as essential oil, zingiberene, zingiberol, and be rich in vitamin B, C, and containing micro manganese, zinc, potassium, sodium, calcium, magnesium, phosphorus, iron,
The elements such as copper.Fructus alpiniae oxyphyllae contains a large amount of " the clever factor "-taurine.Taurine is a kind of B- sulfamic acid, belongs to non-protein
Matter amino acid is a kind of human body institute essential nutrients, is distributed in brain, ovary, uterus, heart, liver, kidney, bone, the blood of human body
In liquid, saliva and milk, to human health, especially the normal growth of infant is developed, and the middle-aged and the old is delayed to decline
It plays an important role always.
Lip dendrobium nobile is combed, top grade is classified as in Shennong's Herbal.Modern medicine pharmacological research shows that dendrobium polysaccharide is improving
It is body immunity, anti-aging, anti-radiation, inhibit tumour, tonifying five zang organs consumptive disease etc. to have obvious effect.The dendrobium nobile not only has feeding
Yin and promoting production of body liquid effect, moreover it is possible to significantly improve superoxide dismutase (SOD) level, reduce lipid peroxide, adjust brain monoamine nerve
Medium level inhibits similar monoamine oxidase (MAO), plays the role of anti-aging.
Black pine is rich in protein, 18 kinds of amino acid to the studies have shown that of the black pine wild edible fungi both at home and abroad
(the 8 kinds of essential amino acids that cannot be synthesized including human body), unsaturated fatty acid, multivitamin, zinc, manganese, iron, calcium, phosphorus, selenium etc.
Essential trace element and sphingolipid, cerebroside, ceramide, triterpene, androsterone, adenosine, truffle acid, sterol, truffle are more
A large amount of metabolites such as sugar, truffle polypeptide have high healthy nutritive value.Wherein androsterone has supporing yang, conditioning endocrine
Remarkable efficacy；Sphingolipid compound has obvious in terms of preventing senile dementia, the hardening of artery congee and antitumor cell toxicity
Activity；Polysaccharide, polypeptide, triterpene have strengthen immunity, anti-aging, fatigue-resisting function, can be used for health-care body-nourishing.
The present invention incorporates the effective component in fructus alpiniae oxyphyllae fruit, comb lip dendrobium nobile, black pine by the technique of ultrasonic wave red
In jasmine tea oil (solvent), increase the edible value and health-care efficacy of oil.The effect of ultrasonic wave can activate the life of certain enzymes and cell
Change process improves the activity of enzyme, accelerates cell metabolism.Correlative study shows that ultrasonic degradation polysaccharide speed is fast, at low cost, ammonia
Base acid content is constant；Ultrasonic wave is for extracting polysaccharide, compared with traditional handicraft compared with recovery rate height, reaction process without loss of material and pair
Reaction；Furthermore ultrasonic wave can also be used in a variety of glucans of degradation extraction etc..
Ultrasonic extraction is a kind of purely mechanic abstraction technique, extracts target from natural plants and medicinal plant convenient for people and lives
Property substance, to produce the extract of high quality；The technology can be referred to as biological because it thoroughly avoid it is non-natural
Solvent, so as to produce some organic standard produce product.Ultrasonic extraction can obtain the product of high value, these product energy
It is taken as the source of native compound enough to improve the value of food byproducts.Extraction can be both greatly shortened in ultrasonic wave extraction
The time taken can also reduce the destruction of bacterium.Parallel multiple groups extraction can be carried out, therefore production with higher is imitated
Energy；It can get the natural bioactivity substance of high added value；Ultrasonic equipment performance is stablized, easy to operate, non-maintaining.
The low-temperature cold pressing ultrasonic technique used in the present invention not only avoids the unfavorable factor during high temperature oil expression
(destroy bioactivity, influence environment and increase energy consumption etc.), also it has been sufficiently reserved safflower tea oil, fructus alpiniae oxyphyllae, comb lip dendrobium nobile and black
Bioactivity in truffle and natural flavour mountaineous.Intelligence development safflower tea oil made of this money cold press ultrasound, color: golden yellow limpid, taste: intelligence development
Light perfume (having fructus alpiniae oxyphyllae volatile oil taste), can be used in cold and hot dish, can also admix in rice (containing gruel), noodles and rice noodles and eat
With；The effective component being extracted in fructus alpiniae oxyphyllae, comb lip dendrobium nobile and black pine simultaneously, so that nutritional ingredient of the present invention is more abundant,
The function of improving immunity is also had both.
Intelligence development safflower tea oil of the present invention shows through the graduate detection of Yunnan Province's product quality supervision and inspection: oleic acid accounts for
75.20%, linoleic acid accounts for 7.64%, and linolenic acid accounts for 0.498%, and palmitoleic acid accounts for 12.60%.Reach healthcare function and preferably
Nutritive index.
Specific embodiment:
Experimental example 1: 3000 kilograms of tea fruit of Tengchong Gaoligong Shan Mountain safflower tea oil tree, comb lip dendrobium nobile 90 by 150 grams of fructus alpiniae oxyphyllae
Gram, 120 grams of black pine.
A kind of production method of intelligence development safflower tea oil, it is characterized in that:
1, safflower tea oil is produced
(1) stack retting: the camellia oleifera fruit of collection is placed on indoor stack retting 6 days, allows tea seed to play afterripening, to increase oil.
(2) sunning, broken shell: the tea fruit after stack retting is shone above after 3-5 days, and the tea seed of tea fruit nature broken shell, tea fruit can separate,
Then it selects, be sieved, Yang Jing, continuing to shine 10-12 days, the organic matters such as starch and soluble sugar is made to be fully converted into grease.It shines
Tea seed be put at aeration-drying collect, when tea seed oil content reaches highest after 40-60 days, then again solarization 1-2 days to mention
High oil recovery, to ensure tea oil quality.
(3) it dries, crush: by tea seed decladding, being placed in 50 DEG C of drying box and dried, the moisture content for controlling tea seed exists
5%, then tea seed is crushed with pulverizer.
(4) cold pressing: tea seed is placed in cold pressing machine, and the temperature of squeezing is 50 DEG C.
(5) filter: the oily coarse filtration that squeezing is completed, the oil that squeezing is completed sequentially pass through the sieve of 60,80,100 mesh,
It is standby at normal temperature to deposit, obtain 1020 grams of safflower tea oil.
2, the fructus alpiniae oxyphyllae fruit, comb lip dendrobium nobile, black pine the preparation of Chinese medicine and wild mushroom: are placed on to about 50 DEG C of baking oven
Fructus alpiniae oxyphyllae fruit, comb lip dendrobium nobile, black pine are broken into coarse powder with pulverizer after drying by middle drying.
3, supersonic oscillations: under normal temperature conditions, the fructus alpiniae oxyphyllae fruit in the step 2, comb lip dendrobium nobile, black pine is thick
Powder is put into the step 1 safflower tea oil obtained, is placed it in ultrasonic extraction tank, is opened ultrasonic device 40 minutes,
Ultrasonic frequency is 20kHz, is allowed to sufficiently merge with safflower tea oil.
4, product oil filters: the safflower tea oil in step 3 being filtered with supercentrifuge, finally obtains intelligence development safflower
918 grams of tea oil product oil.
Experimental example 2: 3500 kilograms of tea fruit of Tengchong Gaoligong Shan Mountain safflower tea oil tree, comb lip dendrobium nobile 60 by 180 grams of fructus alpiniae oxyphyllae
Gram, 80 grams of black pine.
A kind of production method of intelligence development safflower tea oil, it is characterized in that:
1, safflower tea oil squeezes:
(1) stack retting: the camellia oleifera fruit of collection is placed on indoor stack retting 6 days, allows tea seed to play afterripening, to increase oil.
(2) sunning, broken shell: the tea fruit after stack retting is shone above after 3-5 days, and the tea seed of tea fruit nature broken shell, tea fruit can separate,
Then it selects, be sieved, Yang Jing, continuing to shine 10-12 days, the organic matters such as starch and soluble sugar is made to be fully converted into grease.It shines
Tea seed be put at aeration-drying collect, when tea seed oil content reaches highest after 40-60 days, then again solarization 1-2 days to mention
High oil recovery, to ensure tea oil quality.
(3) it dries, crush: by tea seed decladding, being placed in 50 DEG C of baking oven and dried, the moisture content for controlling tea seed exists
8%, tea seed is carried out using pulverizer to be ground into coarse powder.
(4) cold pressing: tea seed is placed in cold pressing machine, and the temperature of squeezing is about 50 DEG C.
(5) filter: the oily coarse filtration that squeezing is completed, the oil that squeezing is completed sequentially pass through the sieve of 60,80,100 mesh,
It is standby at normal temperature to deposit, obtain 1225 grams of safflower tea oil.
2, the preparation of Chinese medicine and wild mushroom: the fructus alpiniae oxyphyllae fruit, comb lip dendrobium nobile, black pine are placed in 50 DEG C of baking oven
Fructus alpiniae oxyphyllae fruit, comb lip dendrobium nobile, black pine are broken into coarse powder with pulverizer after drying by drying.
3, supersonic oscillations: under normal temperature conditions, by fructus alpiniae oxyphyllae fruit, comb the lip dendrobium nobile, black pine powder in the step 2
It is put into the step 1 safflower tea oil obtained.It places it on ultrasonic device, opens ultrasonic device 20 minutes, ultrasonic wave
Frequency is 40kHz, is allowed to sufficiently merge with safflower tea oil.
5, finished product filters: the safflower tea oil in the step 3 being filtered with supercentrifuge, it is red to finally obtain intelligence development
1103 grams of jasmine tea oil finished product.
Pharmacodynamic experiment
Inventor once entrusted research and development centre, Yunnan glamour Han Dao pharmaceutical Co. Ltd to intelligence development in this project R&D process
Safflower tea oil has carried out the experiment of " murine interleukin regeneration function, thymus gland and spleen adjustment effect ", is obtained with 6 groups of mouse
Data are analyzed and are counted, specific as follows:
1st group: being formulated produced oil (inventive formulation) stomach-filling with experimental example 1, intragastric administration on mice was given from the 1st~15 day
This oily (0.6ml/kg.bw), wherein when by the 8th, 9,10 3 day, intraperitoneal injection of cyclophosphamide (80mg/kg.bw).
2nd group: being formulated produced oil (inventive formulation) stomach-filling with experimental example 2, intragastric administration on mice was given from the 1st~15 day
This oily (0.6ml/kg.bw), wherein when by the 8th, 9,10 3 day, intraperitoneal injection of cyclophosphamide (80mg/kg.bw).
3rd group: with safflower open country tea oil (200ml/ bottles, scientific research lot number 20180101, character: transparent light golden yellow；Purchased from river
Xi Shisanfu Food Co., Ltd) stomach-filling, to intragastric administration on mice this oily (0.6ml/kg.bw) from the 1st~15 day, wherein to the
8,9,10 3 days when, intraperitoneal injection of cyclophosphamide (80mg/kg.bw)；
4th group: with Extra Virgin (200ml/ bottles, scientific research lot number 20180102, character: transparent light golden yellow；Purchase
From Real Betis Spain imported with original packaging) stomach-filling, gave intragastric administration on mice this oily (0.6ml/kg.bw) from the 1st~15 day, wherein arriving
At the 8th, 9,10 3 day, intraperitoneal injection of cyclophosphamide (80mg/kg.bw)；
5th group: with distilled water stomach-filling, intragastric administration on mice distilled water (0.6ml/kg.bw) was given from the 1st~15 day, wherein arriving
At the 8th, 9,10 3 day, intraperitoneal injection of cyclophosphamide (80mg/kg.bw)；
6th group: with distilled water stomach-filling, giving intragastric administration on mice distilled water (0.6ml/kg.bw) from the 1st~15 day
Experimental rat are as follows: after Kunming mouse adaptive feeding 3 days, 60 qualified animals are randomly divided into 6 groups, often
Group 10, half male and half female.It weighs within the 1st, 4,7,11,14 day in test primary, each group carries out white blood cell count(WBC) after modeling, with
Judge modeling success or not；In addition to the 5th, 6 group, remaining 4 groups continuously feed oil 15 days after, Yu Ci each group take respectively blood carry out WBC,
RBC, PLT are counted, execution animal takes thymus gland, spleen weighing.
Observe result:
Mouse WBC, RBC, PLT count results (± SD) n=number of animals at table 1 the 11st day
Statistical analysis: at the 11st day, each group WBC has significant difference (P < 0.01) compared with blank group, illustrates modeling
Success.There was no significant difference compared with the 5th group (P > 0.05) by 3rd, 4 group of WBC.1st, 2 group of WBC has significantly compared with the 5th group
Sex differernce (P < 0.05).Each group RBC number has reduction compared with the 6th group, but there was no significant difference (P > 0.05).1-4 group
PLT number has reduction compared with the 6th group, but there was no significant difference (P > 0.05)；But there is significant difference (P compared with the 5th group
< 0.05).
Mouse WBC, RBC, PLT count results (± SD) n=number of animals at table 2 15 days
Statistical analysis: at the 15th day, each group WBC has rise.3rd, 4 group of WBC is compared with the 5th group, and there was no significant difference
(P > 0.05).1st, 2 group of WBC has significant difference (P < 0.05) compared with the 5th group.1-4 group RBC number is higher than the 5th group,
But there was no significant difference (P > 0.05).1-4 group PLT number than the 5th group group is high, but there was no significant difference (P > 0.05).
When test was to the 11st day, i.e. the 1st after intraperitoneal injection of cyclophosphamide 80mg/kg.bw modeling day, 1-4 group animal
WBC number declines, and has compared with the 6th group significant difference (P < 0.05), and the 5th group of (cyclophosphamide) WBC number decline is the brightest
It is aobvious, prompt this test cyclophosphamide modeling success.
It is tested to the 15th day, 1-4 group animal WBC number is gone up, and is above the 5th group (cyclophosphamide)；But the 3rd group and
There was no significant difference compared with the 5th group (P > 0.05) for 4th group of WBC number；1st group and the 2nd group of WBC number have conspicuousness compared with the 5th
Difference (P < 0.05).1st group and the 2nd group of WBC number have significant difference (P < 0.05) compared with the 3rd group and the 4th group of WBC number.
1st group and the 2nd group of WBC number compare that there was no significant difference (P > 0.05).
In test the 11st day, each group decreased compared with the 6th group for RBC number and PLT number, but there was no significant difference (P >
0.05) when, by the 15th day, 1-4 group RBC number and PLT number are above the 5th group, but without significant difference (P > 0.05).
3 modeling mice organs weight of table and its coefficient results (± SD) n=number of animals
Statistical analysis: thymic weight and its coefficient, the 3rd, 4 group and the 5th group there was no significant difference (P > 0.05)；1st, 2
Group is higher than the 5th group, there is significant difference (P < 0.05).Each group spleen weight and its coefficients comparison there was no significant difference (P >
0.05)。
Thymic weight and its coefficient: the 3rd, 4 groups with the 5th group there was no significant difference (P > 0.05)；1st, 2 group is higher than the 5th
Group (cyclophosphamide CP) has significant difference (P < 0.05).Each group spleen weight and its coefficients comparison there was no significant difference (P >
0.05).Oil of the invention has certain protective effect to the thymus gland during chemotherapy (cyclophosphamide).
The result shows that: with the intraperitoneal injection modeling success of 80mg/kg.bw cyclophosphamide.Each group mouse weight is equal during experiment
There is growth.Leucocyte (WBC) number of 1st group (1 oil of experimental example) and the 2nd group (2 oil of experimental example) gos up obviously, with the 5th group of (ring
Phosphamide CP) compare and has significant difference (P < 0.05)；1st group (experimental example 1 oil) and the 2nd group (experimental example 2 is oily) are to abdominal cavity
Injection cyclophosphamide modeling mouse WBC regeneration function has apparent adjustment effect.1st group (1 oil of experimental example) and the 2nd group of (reality
Test the oil of example 2) to the regeneration function of mouse WBC, to the adjustment effect of thymus gland and spleen be superior to the 3rd group (safflower open country tea oil) and
4th group (Spain's olive oil), there is significant difference (P < 0.05).3rd group (safflower open country tea oil) and the 4th group of (Spain's olive
Olive oil) compared with the 5th group of (cyclophosphamide CP) WBC, there was no significant difference (P > 0.05).
The results showed that a kind of leucocyte of the intelligence development safflower tea oil of the present invention to intraperitoneal injection of cyclophosphamide modeling mouse
With regeneration function, commercially available safflower open country tea oil and Spain's olive oil are superior to the adjustment effect of thymus gland and spleen, illustrate this
Invention has the effect of improving immunity.
Claims (6)
1. a kind of intelligence development safflower tea oil, it is characterised in that raw material composition are as follows: the dry tea fruit 3000-3500 of Tengchong safflower tea oil tree
Gram, 150-180 grams of fructus alpiniae oxyphyllae, 60-90 grams of lip dendrobium nobile of comb, 80-120 grams of black pine.
A kind of production method of intelligence development safflower tea oil is provided described in 2. a kind of claim 1 is any, it is characterized in that: including following
Step:
(1) safflower tea oil squeezes: tea fruit collected squeezed into safflower tea oil；
(2) preparation of traditional Chinese medicine powder and wild mushroom powder: being placed on the fructus alpiniae oxyphyllae fruit, comb lip dendrobium nobile, black pine in baking oven and dry,
Again fructus alpiniae oxyphyllae fruit, comb lip dendrobium nobile, black pine are carried out being ground into coarse powder with pulverizer after drying；
(3) supersonic oscillations:
Under normal temperature conditions, fructus alpiniae oxyphyllae fruit, comb lip dendrobium nobile, the black pine coarse powder in the step 2 are put into step 1 and are obtained
Safflower tea oil in, with being placed in ultrasonic extraction tank, open ultrasonic device 20-40 minutes, make three taste medicinal materials and safflower tea oil
In effective component sufficiently merged；
(4) finished product filters
It by the safflower tea oil in the step 3, is filtered by supercentrifuge, finally obtains intelligence development safflower tea oil finished product 918-
1103 grams.
3. a kind of production method of intelligence development safflower tea oil according to claim 2, it is characterised in that: the step (1)
Specific processing are as follows: a. stack retting: the camellia oleifera fruit of collection is placed on indoor stack retting 6-8 days, increases oil；
B. sunning, broken shell: the tea fruit after stack retting is shone above after 3-5 days, the tea seed of tea fruit nature broken shell, tea fruit can separate, then
It selects, be sieved, Yang Jing, continuing to shine 10-12 days；The tea seed shone is put at aeration-drying and collects, the tea seed after 40-60 days
When oil content reaches highest, then shine 1-2 days again；
C. it dries, crush: by tea seed decladding, being placed in 50-60 DEG C of baking oven and dried, control the moisture content of tea seed in 5%-
8%, then tea seed is crushed with pulverizer；
D. cold pressing: tea seed is placed in squeezer and is squeezed；
E. it filters: the oily coarse filtration that squeezing is completed, it is standby at normal temperature to deposit, obtain 1020-1225 grams of safflower tea oil.
4. a kind of production method of intelligence development safflower tea oil according to claim 2, it is characterised in that: the step (2) is dried
The temperature of case is 50-60 DEG C.
5. a kind of production method of intelligence development safflower tea oil according to claim 2, it is characterised in that: the step (3) is super
The ultrasonic frequency of sound wave extractor is 20-60kHz.
6. a kind of production method of intelligence development safflower tea oil according to claim 3, it is characterised in that: the cold pressing,
Pressing temperature is 50-60 DEG C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910059032.1A CN109652202A (en) | 2019-01-22 | 2019-01-22 | A kind of intelligence development safflower tea oil and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910059032.1A CN109652202A (en) | 2019-01-22 | 2019-01-22 | A kind of intelligence development safflower tea oil and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109652202A true CN109652202A (en) | 2019-04-19 |
Family
ID=66120483
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910059032.1A Pending CN109652202A (en) | 2019-01-22 | 2019-01-22 | A kind of intelligence development safflower tea oil and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109652202A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112690351A (en) * | 2020-12-26 | 2021-04-23 | 中国热带农业科学院热带作物品种资源研究所 | Millettia speciosa-intelligence-benefiting tea beverage as well as preparation method and application thereof |
| CN113481047A (en) * | 2021-07-21 | 2021-10-08 | 湖南神农国油生态农业发展有限公司 | Preparation process of low-temperature cold-extraction moderately refined tea oil |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101692854A (en) * | 2009-10-12 | 2010-04-14 | 华南农业大学 | Method for preparing edible safflower tea oil |
| CN104073349A (en) * | 2014-06-16 | 2014-10-01 | 南京泽朗医药科技有限公司 | Method for extracting alpinia oxyphylla volatile oil |
| CN105535032A (en) * | 2016-03-04 | 2016-05-04 | 陈爱华 | Extraction method of truffle polysaccharides and health-care truffle product |
| CN106260108A (en) * | 2016-08-18 | 2017-01-04 | 贵州石阡佛顶山野生油茶油业有限公司 | A kind of Chinese medicine health-care Oleum Camelliae and preparation method thereof |
| CN107156331A (en) * | 2017-06-20 | 2017-09-15 | 贵州益寿农业科技有限公司 | A kind of tea oil for possessing effect of weight reducing |
| CN107213329A (en) * | 2017-06-14 | 2017-09-29 | 贵州祥驰农业开发有限公司 | A kind of Chinese medicine health-care tea oil |
-
2019
- 2019-01-22 CN CN201910059032.1A patent/CN109652202A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101692854A (en) * | 2009-10-12 | 2010-04-14 | 华南农业大学 | Method for preparing edible safflower tea oil |
| CN104073349A (en) * | 2014-06-16 | 2014-10-01 | 南京泽朗医药科技有限公司 | Method for extracting alpinia oxyphylla volatile oil |
| CN105535032A (en) * | 2016-03-04 | 2016-05-04 | 陈爱华 | Extraction method of truffle polysaccharides and health-care truffle product |
| CN106260108A (en) * | 2016-08-18 | 2017-01-04 | 贵州石阡佛顶山野生油茶油业有限公司 | A kind of Chinese medicine health-care Oleum Camelliae and preparation method thereof |
| CN107213329A (en) * | 2017-06-14 | 2017-09-29 | 贵州祥驰农业开发有限公司 | A kind of Chinese medicine health-care tea oil |
| CN107156331A (en) * | 2017-06-20 | 2017-09-15 | 贵州益寿农业科技有限公司 | A kind of tea oil for possessing effect of weight reducing |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112690351A (en) * | 2020-12-26 | 2021-04-23 | 中国热带农业科学院热带作物品种资源研究所 | Millettia speciosa-intelligence-benefiting tea beverage as well as preparation method and application thereof |
| CN112690351B (en) * | 2020-12-26 | 2023-10-27 | 中国热带农业科学院热带作物品种资源研究所 | A Niu Dali-puzzle tea beverage and its preparation method and application |
| CN113481047A (en) * | 2021-07-21 | 2021-10-08 | 湖南神农国油生态农业发展有限公司 | Preparation process of low-temperature cold-extraction moderately refined tea oil |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103099089B (en) | Health-care product for reducing blood sugar and blood pressure, relaxing bowels, losing weight, resisting fatigue and improving sexual function and production technology thereof | |
| CN102242070B (en) | Method for artificially culturing paecilomyces cicadae and application of culturing product thereof | |
| CN102919836B (en) | Health-care product capable of reducing blood glucose, releasing pressure, reducing lipid, relaxing bowel, beautifying, losing weight and resisting fatigue and production process thereof | |
| CN102907604B (en) | Health-care product having effects of reducing blood sugar and pressure, losing weight, relaxing bowels, maintaining beauty and resisting fatigue and production process thereof | |
| CN103725469B (en) | A kind of health dry red winew | |
| CN101518336A (en) | Nutrition food with oxidation resistance function and preparation method thereof | |
| CN102344876A (en) | Nine-medicine Shengzi red fruit wine and preparation method thereof | |
| CN104095231B (en) | A kind of health products containing agate coffee, the stem of noble dendrobium, American Ginseng and preparation method thereof | |
| CN105614678A (en) | Selenium-rich salicornia nutrition and health care noodles and production technology thereof | |
| CN103610072A (en) | Preparation method for blood-sugar-reducing sea cucumber oral liquid | |
| CN109652202A (en) | A kind of intelligence development safflower tea oil and preparation method thereof | |
| CN101564180A (en) | Walnut total nutriment and soft capsule and health products containing same | |
| CN103719855B (en) | Nutritious food and production method thereof | |
| WO2020098154A1 (en) | Ceratonia siliqua fruit composition and preparation method therefor and use thereof | |
| CN109527547A (en) | A kind of preparation method of lactobacillus-fermented mulberries polyoses oral liquid | |
| CN102090637A (en) | Collagen-containing compound nutritious powder | |
| CN112042835A (en) | A kind of non-full nutrition special medical food with hypolipidemic effect and preparation method thereof | |
| CN106107978A (en) | A kind of unknown mallow health care oral liquid of blood pressure lowering | |
| CN102302114A (en) | Pollen-containing health-care food and preparation method thereof | |
| CN104585574A (en) | Propolis soft capsule product and preparation method thereof | |
| CN104055115B (en) | A kind of health products containing agate coffee, the stem of noble dendrobium and Panax Japonicus Var. Major and preparation method thereof | |
| CN108813500B (en) | Health-preserving honey paste with effects of tonifying middle-jiao and Qi, nourishing blood and soothing nerves and regulating human body functions | |
| CN106942659B (en) | Preparation method of health-care momordica charantia buccal tablets | |
| CN104524180A (en) | Maca compound tablet, and preparation method and applications thereof | |
| CN103610068A (en) | Preparation method for blood-fat-reducing sea cucumber oral liquid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |